Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Q32 Bio (QTTB)
NASDAQ:QTTB
Q32 Bio (QTTB) Stock Price & Analysis
703 Followers
QTTB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.24 - $26.64
Previous Close$21.3
Volume15.74K
Average Volume (3M)25.00K
Market Cap
$255.53M
Enterprise Value$174.20M
Total Cash (Recent Filing)$82.65M
Total Debt (Recent Filing)$1.32M
Price to Earnings (P/E)-0.6
Beta0.99
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-35.16
Shares Outstanding3,229,641
10 Day Avg. Volume32,633
30 Day Avg. Volume24,999
Standard Deviation0.19
R-Squared0.00072
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.74
Price to Sales (P/S)60.01
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue150.69
Enterprise Value/Gross Profit150.69
Enterprise Value/Ebitda-1.95
Forecast
1Y Price Target
$47.50Price Target Upside121.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Q32 Bio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
QTTB FAQ
What was Q32 Bio’s price range in the past 12 months?
Q32 Bio lowest stock price was $8.24 and its highest was $26.64 in the past 12 months.
What is Q32 Bio’s market cap?
Currently, no data Available
When is Q32 Bio’s upcoming earnings report date?
Q32 Bio’s upcoming earnings report date is May 13, 2024 which is in 16 days.
How were Q32 Bio’s earnings last quarter?
Q32 Bio released its earnings results on Mar 13, 2024. The company reported -$5.001 earnings per share for the quarter, beating the consensus estimate of -$5.4 by $0.399.
Is Q32 Bio overvalued?
According to Wall Street analysts Q32 Bio’s price is currently Undervalued.
Does Q32 Bio pay dividends?
Q32 Bio does not currently pay dividends.
What is Q32 Bio’s EPS estimate?
Q32 Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q32 Bio have?
Q32 Bio has 11,929,528 shares outstanding.
What happened to Q32 Bio’s price movement after its last earnings report?
Q32 Bio reported an EPS of -$5.001 in its last earnings report, beating expectations of -$5.4. Following the earnings report the stock price went up 1.424%.
Which hedge fund is a major shareholder of Q32 Bio?
Among the largest hedge funds holding Q32 Bio’s share is Western Standard Llc. It holds Q32 Bio’s shares valued at N/A.
---
Q32 Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$47.50 (121.14% Upside)
$47.50 (121.14% Upside)
Hedge Fund Trend
Decreased
By 13.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.1%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.16%
12-Months-Change
Fundamentals
Return on Equity
-90.02%
Trailing 12-Months
Asset Growth
33.99%
Trailing 12-Months
Company Description
Q32 Bio
Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.
---
QTTB Stock 12 Months Forecast
Average Price Target
$47.50
▲(121.14% Upside)
Technical Analysis
Best Analysts Covering QTTB
1 Year
1 Year Success Rate
1/14 ratings generated profit
1 Year Average Return
-49.69%
reiterated a buy rating 12 months ago
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 7.14% of your transactions generating a profit, with an average return of -49.69% per trade.
---